Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) EBT (2016)

Historic EBT for Tenax Therapeutics (TENX) over the last 6 years, with Q4 2016 value amounting to -$42.2 million.

  • Tenax Therapeutics' EBT fell 24885.8% to -$42.2 million in Q4 2016 from the same period last year, while for Dec 2016 it was -$63.5 million, marking a year-over-year increase of 5264.48%. This contributed to the annual value of -$17.6 million for FY2024, which is 12643.43% down from last year.
  • Latest data reveals that Tenax Therapeutics reported EBT of -$42.2 million as of Q4 2016, which was down 24885.8% from -$4.5 million recorded in Q3 2016.
  • In the past 5 years, Tenax Therapeutics' EBT registered a high of $108.6 million during Q2 2012, and its lowest value of -$118.0 million during Q2 2013.
  • For the 4-year period, Tenax Therapeutics' EBT averaged around -$8.8 million, with its median value being -$4.6 million (2016).
  • Data for Tenax Therapeutics' EBT shows a peak YoY increase of 371057.81% (in 2012) and a maximum YoY decrease of 35790.41% (in 2012) over the last 5 years.
  • Quarter analysis of 4 years shows Tenax Therapeutics' EBT stood at -$1.6 million in 2012, then tumbled by 7512.64% to -$118.0 million in 2013, then surged by 89.74% to -$12.1 million in 2015, then plummeted by 248.86% to -$42.2 million in 2016.
  • Its EBT stands at -$42.2 million for Q4 2016, versus -$4.5 million for Q3 2016 and -$4.7 million for Q2 2016.